Arch Biopartners Balance Sheet

Financials in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cash & Equivalents	0.44	0	0	0.83	0.51	0.45
Cash & Short-Term Investments	0.44	0	0	0.83	0.51	0.45
Cash Growth	4255.02%	-29.23%	-99.64%	64.17%	12.96%	-31.43%
Accounts Receivable	-	-	0.72	-	-	1.85
Other Receivables	0.02	0.08	0.17	0.3	0.09	0.35
Receivables	0.02	0.08	0.9	0.3	0.09	2.2
Prepaid Expenses	0.01	0.02	0.03	0.04	0.03	0.02
Total Current Assets	0.46	0.1	0.94	1.17	0.62	2.67
Total Assets	0.46	0.1	0.94	1.17	0.62	2.67
Accounts Payable	1.35	1.04	2.32	0.39	0.49	0.96
Accrued Expenses	-	-	0.04	0.17	0.19	0.42
Short-Term Debt	2.73	2.84	2.27	1.71	-	1.8
Current Portion of Long-Term Debt	-	-	0.5	2.6	2.1	-
Current Unearned Revenue	0.03	0.1	0.15	1.1	-	-
Total Current Liabilities	4.11	3.99	5.28	5.98	2.78	3.19
Long-Term Debt	-	-	-	0.7	2.31	3.36
Total Liabilities	4.11	3.99	5.28	6.68	5.09	6.55
Common Stock	21.88	20.35	18.25	15.88	15.55	14.76
Additional Paid-In Capital	7.38	6.6	6.68	6.66	4.7	4.68
Retained Earnings	-35.6	-33.52	-31.97	-28.05	-24.72	-23.32
Comprehensive Income & Other	2.69	2.69	2.69	-	-	-
Shareholders' Equity	-3.64	-3.88	-4.35	-5.51	-4.47	-3.88
Total Liabilities & Equity	0.46	0.1	0.94	1.17	0.62	2.67
Total Debt	2.73	2.84	2.77	5.02	4.41	5.16
Net Cash (Debt)	-2.29	-2.84	-2.77	-4.18	-3.91	-4.72
Net Cash Per Share	-0.03	-0.04	-0.04	-0.07	-0.06	-0.08
Filing Date Shares Outstanding	67.93	66.93	64.94	62.76	62.4	61.36
Total Common Shares Outstanding	67.73	66.11	64.65	62.6	62.33	61.96
Working Capital	-3.64	-3.88	-4.35	-4.81	-2.16	-0.52
Book Value Per Share	-0.05	-0.06	-0.07	-0.09	-0.07	-0.06
Tangible Book Value	-3.64	-3.88	-4.35	-5.51	-4.47	-3.88
Tangible Book Value Per Share	-0.05	-0.06	-0.07	-0.09	-0.07	-0.06